HeraMED Limited (ASX:HMD)

Australia flag Australia · Delayed Price · Currency is AUD
0.0460
-0.0020 (-4.17%)
Apr 29, 2026, 2:06 PM AEST
187.50%
Market Cap 55.44M
Revenue (ttm) 431.61K
Net Income (ttm) -4.13M
Shares Out 1.15B
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 195,825
Average Volume 3,075,042
Open 0.0480
Previous Close 0.0480
Day's Range 0.0460 - 0.0480
52-Week Range 0.0060 - 0.0550
Beta 0.33
RSI 54.00
Earnings Date May 28, 2026

About HeraMED

HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a digital maternity and women’s health platform that focuses on improving clinical outcomes while supporting more efficient and accessible models of care. The company has a collaboration agreement with Mayo Clinic. HeraMED Limited was founded in 2011 and is based in Haw... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2011
Country Australia
Stock Exchange Australian Securities Exchange
Ticker Symbol HMD
Full Company Profile

Financial Performance

In 2025, HeraMED's revenue was 431,605, a decrease of -10.31% compared to the previous year's 481,227. Losses were -4.13 million, -24.75% less than in 2024.

Financial Statements

News

There is no news available yet.